NLRP3 and congenital rubella syndrome: NLRP3 inflammasome is a key platform for IL-1 maturation in CRS, immune cells such as macrophages and monocytes are overactivated, leading to a significant activation of NLRP3 inflammasomes and the release of a large amount of IL-1 [32].